Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Given Imaging Ltd. Lowers FY 2012 Revenue Guidance; Reaffirms FY 2012 EPS Guidance
Given Imaging Ltd. announced that as a result of ongoing economic weakness in Europe, associated with the weak Euro and the lower than forecast revenue in the Asia Pacific region in the first half of 2012, the Company is lowering its revenue guidance for fiscal 2012 from between $190 million and $200 million to between $185 and $190 million. Despite lowering top-line guidance, the Company believes that initiatives to maximize profitability will enable the Company to achieve its earnings per share (EPS) guidance of between $0.45 and $0.55 on a GAAP basis, and between $0.70 and $0.80 on a non-GAAP basis.
Latest Developments for Given Imaging Ltd
- Given Imaging Ltd Reaffirms FY 2013 Guidance
- Given Imaging Ltd Issues FY 2013 Revenue Guidance In Line With Analysts' Estimates; EPS Guidance Above Analysts' Estimates
- Given Imaging Ltd Halts Sale Review, Investor May Sell Stake-Reuters
- Given Imaging Ltd Submits PillCam COLON 2 Application to FDA for U.S. Regulatory Clearance
Latest Key Developments in Medical
- Share this
- Link this
- Digg this


Follow Reuters